Video narration
Doctor, imagine we're meeting after a routine osteoarthritis follow-up. You've reviewed the patient's progress and are weighing options in their individual clinical context. The patient's response and priorities shape that decision. I'd like to introduce a product presented for osteoarthritis, with one specific point for you to verify. The stated composition is undenatured collagen peptide, providing 20 milligrams of collagen peptide. That describes what the product contains; it does not, on its own, establish symptom relief, functional benefit, safety, or superiority over another option. I won't claim that no other product offers this, or attach a clinical outcome to the ingredient. Either claim needs substantiation. The product label and clinical evidence were not provided for this discussion, so I can't characterize them. Doctor, assess that 20 milligrams of undenatured collagen peptide against the approved product information and supporting evidence.